期刊文献+

1例结核患者并发真菌感染的药学服务实践 被引量:1

Pharmaceutical Care in Tuberculosis Patients with Fungal Infection by Clinical Pharmacists
下载PDF
导出
摘要 临床药师参与1例结核患者并发真菌感染治疗的全过程,基于伏立康唑治疗药物监测手段,结合药品说明书、用药指南及文献,为临床医师提供药学服务。治疗过程中,临床药师提出伏立康唑剂量调整建议,与医师共同制定个体化治疗方案并随时调整,提高了治疗效果。结果表明,治疗药物监测是临床药师提供合理用药建议的有效技术手段,有利于提高临床药师干预的可靠性。临床药师通过有效的药学服务,为个体化治疗的逐步完善提供了一定的支持。 Clinical pharmacists participated in the treatment of a case of tuberculosis complicated with fungal infection,provided pharmaceutical services to clinicians based on the therapeutic drug monitoring(TDM)method of voriconazole,combining the drug instructions,guidelines and literature.During the course of treatment,clinical pharmacists put forward suggestions on the dose adjustment of voriconazole,and worked together with clinicians to develop individualized treatment plan,which brought about greater improvements in patient outcome.The results showed that TDM is an effective technical means for clinical pharmacists to provide advice on rational drug use,which greatly enhances the reliability of clinical pharmacists’intervention.Clinical pharmacists provide some support for the gradual improvement of personalized medicine through effective pharmaceutical services.
作者 叶丽冰 叶勇 袁玉梅 杨水新 Ye Libing;Ye Yong;Yuan Yumei;Yang Shuixin(Department of Pharmacy,Huzhou Central Hospital,Huzhou 313000,Zhejiang,China)
出处 《药物流行病学杂志》 CAS 2020年第3期182-186,共5页 Chinese Journal of Pharmacoepidemiology
基金 浙江省医药卫生科技计划一般项目(编号:2015KYB374).
关键词 真菌感染 伏立康唑 治疗药物监测 药学服务 Fungal infection Voriconazole Therapeutic drug monitoring Pharmaceutical services
  • 相关文献

参考文献4

二级参考文献34

  • 1卫生部疾病预防控制局,卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南[M].2版.北京:人民卫生出版社,2008:3.
  • 2Pozniak AL, Coyne KM, Miller RF, et al. British HIV association guidelines for the treatment of TB/HIV coinfection 2011 [J]. HIV Med, 2011, 12(9): 517-524.
  • 3National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control[M]. London: National Institute for Health and Clinical Excellence (UK), 2011: 21.
  • 4Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 199811]. Thorax, 1998, 53(7): 536-548.
  • 5British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn H, Ashman N, et al. Guidelines for the prevention and management of Mycobacteriurn tuberculosis infection and disease in adult patients with chronic kidney disease[J]. Thorax, 2010, 65(6): 557-570.
  • 6Treatment Committee of the Japanese Society for Tuberculosis, International Exchanging committee of the Japanese Society for Tuberculosis. Clinical use of rifabutin, a rifamycin- class antibiotic, for the treatment of tuberculosis (a supplement to the 2008 revision of "standards for tuberculosis care")[J]. Kekkaku, 2011, 86(1): 43.
  • 7Swaziland National Tuberculosis Control Programme. Drug resistant tuberculosis management guidelines and manual for Swaziland[M]. Swaziland: Ministry of Health, 2008: 22-24, 30-34.
  • 8National Department of Health. National tuberculosis management guidelines[M]. South Africa: National Department of Health, 2009: 37-39, 77, 116.
  • 9WHO Guidelines Approved by the Guidelines Review Committee. WHO policy on collaborative TB/HIV activities: guidelines for National programmes and other stakeholders[M]. Geneva: World Health Organization, 2012: 30.
  • 10Ministry of Health. Guidelines for tuberculosis control in New Zealand 2010[M]. Wellington: Ministry of Health, 2010:58-61.

共引文献27

同被引文献12

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部